ooooooh, what a Sh*****t I bought them, a pretty Good Chunk, at...

ooooooh, what a Sh*****t I bought them, a pretty Good Chunk, at 6.6c I mean

• Antisense Therapeutics (ANP) has presented new data to support its ATL1102 drug and also filed another patent in Australia
• The biotechnology company reports testing found a statistically significant modulation in two Duchenne Muscular Dystrophy (DMD) disease modifier proteins
• The result supports the potential of ATL1102 in ambulant DMD and fibrotic conditions
• ANP has lodged a provisional patent application to cover the new data and associated drug applications
• Shares in Antisense Therapeutics are up 5 per cent at 21 cents per share at 11:50 am AEST

http://themarketherald.com.au/antisense-therapeutics-asxanp-presents-new-data-files-australian-patent-2021-09-24/